<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2017.2971</article-id>
<article-id pub-id-type="publisher-id">ijmm-39-06-1548</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Oligomeric proanthocyanidins protects A549 cells against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress via the Nrf2-ARE pathway</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>Chao</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Jin</surname><given-names>Weiguo</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Shi</surname><given-names>Hongcan</given-names></name><xref ref-type="corresp" rid="c1-ijmm-39-06-1548"/></contrib>
<aff id="af1-ijmm-39-06-1548">Department of Cardiothoracic Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China</aff></contrib-group>
<author-notes>
<corresp id="c1-ijmm-39-06-1548">Correspondence to: Professor Hongcan Shi, Department of Cardiothoracic Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, 98 West Nantong Road, Yangzhou, Jiangsu 225001, P.R. China, E-mail: <email>hongcanshi01@163.com</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>04</month>
<year>2017</year></pub-date>
<volume>39</volume>
<issue>6</issue>
<fpage>1548</fpage>
<lpage>1554</lpage>
<history>
<date date-type="received">
<day>06</day>
<month>02</month>
<year>2016</year></date>
<date date-type="accepted">
<day>07</day>
<month>04</month>
<year>2017</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year></permissions>
<abstract>
<p>Oxidative signaling and oxidative stress contribute to aging, cancer and diseases resulting from lung fibrosis. In this study, we explored the anti-oxidative potential of oligomeric proanthocyanidins (OPCs), natural flavonoid compounds. We examined the protective effects of OPCs against hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced oxidative stress in non-small cell lung cancer cells (A549). We demonstrated that OPC markedly attenuated H<sub>2</sub>O<sub>2</sub>-induced A549 cell viability, as shown by by 3-&#x0005B;4,5-dimethylthiazol-2-yl)&#x0005D;-2,5-diphenyl-tetrazolium bromide (MTT) assay. At the same time, OPC inhibited H<sub>2</sub>O<sub>2</sub>-induced oxidative stress by significantly increasing the activities of superoxide dismutase, catalase and glutathione, and reducing the levels of reactive oxygen species (ROS) and malondialdehyde (MDA). Treatment of the A549 cells with OPC significantly promoted the nuclear translocation of NF-E2-related factor 2 (Nrf2) and significantly enhanced the expression of its target genes &#x0005B;heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1) and thioredoxin reductase 1 (TXNRD1)&#x0005D; with different fold change values at both the mRNA and protein level. The knockout of Nrf2 using CRISPR/Cas9 technology attenuated OPC-mediated ARE gene transcription, and almost abolished the OPC-mediated protective effects against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. On the whole, our study suggests that OPC plays an important role in controlling the antioxidant response of A549 cells via the Nrf2-ARE pathway.</p></abstract>
<kwd-group>
<kwd>oxidative stress</kwd>
<kwd>oligomeric proanthocyanidin</kwd>
<kwd>hydrogen peroxide</kwd>
<kwd>NF-E2-related factor 2</kwd>
<kwd>CPISPR/Cas9</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Oligomeric proanthocyanidins (OPCs) are extensively distributed in the plant kingdom and are present in high concentrations in certain plant-based foods and beverages (<xref ref-type="bibr" rid="b1-ijmm-39-06-1548">1</xref>). Previous studies have suggested that OPCs provide health benefits, such as a reduced risk of vascular disease and certain types of cancer (<xref ref-type="bibr" rid="b2-ijmm-39-06-1548">2</xref>,<xref ref-type="bibr" rid="b3-ijmm-39-06-1548">3</xref>). OPCs have also been shown to alleviate EtoH-induced liver steatosis and injury in mice, while increasing superoxide dismutase (SOD) activity (<xref ref-type="bibr" rid="b4-ijmm-39-06-1548">4</xref>). OPCs extracted from apples have also been shown to exert antioxidant effects (<xref ref-type="bibr" rid="b5-ijmm-39-06-1548">5</xref>). However, the mechanisms through which OPCs protect cells against oxidative stress require clarification. All living organisms are constantly challenged by internal and external oxidative stress, such as those from drugs, xenobiotics, heavy metals and ionizing radiation, resulting in the increased production of reactive oxygen species (ROS) (<xref ref-type="bibr" rid="b6-ijmm-39-06-1548">6</xref>). ROS include superoxide anion (O<sub>2</sub><sup>&#x02022;&#x02212;</sup>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and the extremely reactive hydroxyl radical (OH<sup>&#x02212;</sup>), with each species displaying a specific range of action and distinct molecular targets (<xref ref-type="bibr" rid="b7-ijmm-39-06-1548">7</xref>,<xref ref-type="bibr" rid="b8-ijmm-39-06-1548">8</xref>). ROS exert significant effects in cancer cells, such as stimulating cellular growth, promoting mutations and inducing resistance to anticancer agents (<xref ref-type="bibr" rid="b9-ijmm-39-06-1548">9</xref>). However, a previous study reviewed the possible therapeutic effects of ROS, suggesting that increased intrinsic ROS-induced stress may prove beneficial as it may enhance the killing effect of therapeutic drugs, as continuous ROS insults decrease the tolerance of cancer cells (<xref ref-type="bibr" rid="b10-ijmm-39-06-1548">10</xref>). Others have reported however, that ROS derived from circulating inflammatory cells contribute to the induction of lung injury (<xref ref-type="bibr" rid="b11-ijmm-39-06-1548">11</xref>).</p>
<p>Nuclear factor erythroid 2-related factor 2 (Nrf2) is commonly known to play a role in the transcriptional regulation of genes encoding antioxidant proteins under stress conditions (<xref ref-type="bibr" rid="b12-ijmm-39-06-1548">12</xref>,<xref ref-type="bibr" rid="b13-ijmm-39-06-1548">13</xref>). Target genes of Nrf2 are involved in the glutathione synthesis, the elimination of ROS and xenobiotic metabolism (<xref ref-type="bibr" rid="b14-ijmm-39-06-1548">14</xref>,<xref ref-type="bibr" rid="b15-ijmm-39-06-1548">15</xref>) and some of these enzymes include SOD, glutathione peroxidase (GSH-Px), glutathione reductase, catalase (CAT), heme oxygenase-1 (HO-1), NAD(P) H quinone dehydrogenase 1 (NQO1) and thioredoxin reductase 1 (TXNRD1). Under normal conditions, Nrf2 is constantly polyubiquitinated by the Keap1-Cul3 E3 ligase and degraded by the 26S proteasome (<xref ref-type="bibr" rid="b16-ijmm-39-06-1548">16</xref>). In the presence of electrophiles or ROS, the ability of the Keap1-Cul3 E3 ligase to target Nrf2 for degradation becomes impaired, stabilized Nrf2 accumulates in the nuclei, heterodimerizes with small Maf proteins and activates target genes for cytoprotection through the antioxidant response element (ARE) with a consensus sequence 5&#x02032;-TGACNNNGC-3&#x02032; (<xref ref-type="bibr" rid="b17-ijmm-39-06-1548">17</xref>,<xref ref-type="bibr" rid="b18-ijmm-39-06-1548">18</xref>). The increased expression of Nrf2 target genes and the increased stability of Nrf2 caused by somatic mutations in Nrf2 and Keap1 are well documented in human cancer (<xref ref-type="bibr" rid="b19-ijmm-39-06-1548">19</xref>). These data indicate that the Nrf2-ARE pathway plays an important role against oxidative stress in cancer cells.</p>
<p>In this sudy, we investigated the anti-oxidative potential of OPCs against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in A549 non-small cell lung cancer cells. OPCs prevent oxidative stress by the accumulation of Nrf2 protein in A549 cells. Further research will be crucial in determining how this inhibitor mediates lung protection and its use as a clinical approach in lung disease.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Chemicals and reagents</title>
<p>OPC (purity &#x02265;98%) was purchased from Zelang Biological Technology Co., Ltd. (Nanjing, China). H<sub>2</sub>O<sub>2</sub> was obtained from Sigma-Aldrich (St. Louis, MO, USA). RPMI-1640 medium and fetal bovine serum (FBS) were obtained from Gibco Industries, Inc. (Grand Island, NY, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), trypsin, L-glutamate, MK-801 and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich. The DCFH-DA ROS assay kit was purchased from the Beyotime Institute of Biotechnology (Jiangsu, China). GSH-Px, CAT and SOD assay kits were procured from Nanjing Jiancheng Bioengineering Institute (Jiangsu, China). The bicinchoninic acid (BCA) protein reagent was from the Beyotime Institute of Biotechnology Co. Ltd., Shanghai, China).</p></sec>
<sec>
<title>Cell culture and treatment</title>
<p>For this study, A549 cells were obtained from the cell bank of the Chinese Academy of Science (Shanghai, China). The A549 cells were cultured in RPMI-1640 medium supplemented with 10% FBS 2 mM L-glutamine, penicillin (100 U/ml) and streptomycin (100 mg/ml) (Wako, Osaka, Japan). The cells were cultured in a humidified incubator containing 5% CO<sub>2</sub> and 95% air at 37&#x000B0;C. The cells were divided into 3 groups based on the treatments as follows: the control group (cells treated with culture medium), H<sub>2</sub>O<sub>2</sub> group (cells exposed to H<sub>2</sub>O<sub>2</sub> for 12 h at a final concentration of 200 <italic>&#x000B5;</italic>M) and the H<sub>2</sub>O<sub>2</sub> + group (cells pre-treated with 50 mg/l OPC for 5 h and then exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h). The cells were subjected to the different treatments and were then subjected to serial analyses, including flow cytometry (FCM), MTT, RT-qPCR and western blot analysis.</p></sec>
<sec>
<title>Assessment of the viable number of cells</title>
<p>Cell viability was performed using the MTT colorimetric assay. Following cell treatment, the medium was removed, and the cells were incubated with 20 <italic>&#x000B5;</italic>l of 5 mg/ml MTT solution for 4 h at 37&#x000B0;C. The dark blue formazan was dissolved with 150 <italic>&#x000B5;</italic>l of DMSO, and the absorbance was measured at 570 nm using a microplate reader (Multiskan MK3, Thermo Fisher Scientific, Waltham, MA, USA). Cell viability was expressed as a percentage of the untreated controls.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>The cells were lysed in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) supplemented with a protease and phosphatase inhibitor cocktail on ice for 15 min, sonicated and centrifuged at 13,000 &#x000D7; g for 15 min. The protein content of the supernatants was measured by BCA reagent (Pierce, Rockford, IL, USA). For the examination of Nrf2 expression, nuclear proteins and cytoplasmic proteins were separated using a Bioepitope Nuclear and Cytoplasmic Extraction kit (Bioworld Technology, St. Louis Park, MN, USA) according to the manufacturer's instructions. Cellular proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes. The membranes were probed with the following primary antibodies (Abs): anti-TXNRD1 (ab16847; 1:1,000; Abcam, Cambridge, MA, USA); anti-Nrf2 (#12721; 1:1,000; Cell Singaling Technology, Danvers, MA, USA); anti-tubulin (ab7291; 1:5,000); anti-HO-1 (ab13248; 1:1,000); lamin B (ab8980; 1:1,000) and anti-NQO1 (ab34173; 1:1,000) (all from Abcam, Cambridge, MA, USA). This was followed by detection using HRP-conjugated secondary antibodies to rabbit IgG (GE Healthcare, Piscataway, NJ, USA).</p></sec>
<sec>
<title>RT-qPCR</title>
<p>Total RNA was extracted from the A549 cells using TRIzol reagent and then reverse transcribed into cDNA using the QuantScript reverse transcription kit (Tiangen, Beijing, China) according to the manufacturer's instructions. Amplification was conducted using a SYBR-Green I PCR kit (Roche, Indianapolis, IN, USA). The PCR reaction conditions were as follows: initial denaturation at 95&#x000B0;C for 10 min, followed by 35 amplification cycles of 95&#x000B0;C for 10 sec, 55&#x000B0;C for 10 sec, 72&#x000B0;C for 15 sec, and a final extension at 72&#x000B0;C for 10 min. &#x003B2;-actin was used as an internal reference gene. Relative values for mRNA levels were calculated using the following formula: fold change = 2<sup>&#x02212;&#x00394;&#x00394;Cq</sup>. The primers used for each gene are listed in <xref rid="tI-ijmm-39-06-1548" ref-type="table">Table I</xref>.</p></sec>
<sec>
<title>Intracellular ROS staining</title>
<p>The cells were incubated with 300 nM dichloro-dihydro-fluorescein diacetate (DCF-DA) (Sigma-Aldrich) for 10 min at 37&#x000B0;C. Following 2 washes in phosphate-buffered saline (PBS)-1X, DCF-DA fluorescence was analyzed using a flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and FlowJo software.</p></sec>
<sec>
<title>Measurement of intracellular GSH-Px, CAT and SOD levels</title>
<p>The A549 cells were plated in 6-well plates at a density of 10&#x000D7;10<sup>4</sup> cells/ml in 2.5 ml of culture medium. After the cells were treated in accordance with the experimental design, the cells were then harvested, disrupted ultrasonically on ice and centrifuged at 2,500 &#x000D7; g for 10 min at 4&#x000B0;C. The supernatants were collected and stored &#x02212;20&#x000B0;C for subsequent analysis. The levels of SOD, GSH-Px and CAT were detected using a Wallac 1420 microplate spectrophotometer (Perkin Elmer, Waltham, MA, USA) using commercially available assay kits (Jiancheng Bioengineering Institute) following the manufacturers' instructions.</p></sec>
<sec>
<title>Determination of the activity of malondialdehyde (MDA)</title>
<p>A reaction mixture containing 0.2 ml cell lysate and 4.2 ml reaction buffer was treated by ultrasound for a certain time using a 22 kHz ultrasound generator (HN-1000Y; Shanghai Hanno Instrument Corp., Shanghai, China) equipped with a tapered horn tip (10-mm end diameter) and boiled for 10 min in water bath, then cooled down and centrifuged at 4,000 rpm for 10 min. the supernatants were measured using a kit purchased from the Nanjing Jiancheng Bioengineering Institute according to the thiobarbituric acid method, which is based on the fact that MDA reacts with thiobarbituric acid to form thiobarbituric acid reactive substances (TBARS) with a maximum absorbance at 530 nm. The experiments were performed in triplicate.</p></sec>
<sec>
<title>Knockout of the Nrf2 gene using the CRISPR/Cas9 mediated genome</title>
<p>Target sequences for CRISPR interference (<xref ref-type="bibr" rid="b20-ijmm-39-06-1548">20</xref>) were designed at CRISPR direct (<ext-link xlink:href="http://crispr.dbcls.jp/" ext-link-type="uri">http://crispr.dbcls.jp/</ext-link>). The target sequences for human Nrf2 were TAGTTCATGAGCGTGA TGAT (exon 3) and TGCCATAATTGTTACACATT (exon 4). Two oligonucleotides with <italic>Bbs</italic>1 restiction sites for guide RNAs (gRNAs) were synthesized by Shenggong (Shanghai, China) and cloned into the PX330 CRISPR/Cas9 vector (Addgene, Cambridge, MA, USA). The cells were transfected the two PX330 guides and PMT-puro by using PolyJet reagent (Invitrogen, Carlsbad, CA, USA). The cells were selected with 1.5 <italic>&#x000B5;</italic>g/ml puromycin and stable clones were maintained in 0.5 <italic>&#x000B5;</italic>g/ml puromycin. The allele-specific primers were designed as follows: forward, GATTCTTGTGAAGCAGTCCAGC and reverse, ATCCAGTGACTTCTTGAATGCTT. Lastly, the potential positive clones from PCR results were selected and this was followed by electrophoresis on a 1% agrose gel. The positive clones will loss about 1000 bp DNA fragment.</p></sec>
<sec>
<title>DNA gel electrophoresis</title>
<p>First, the cells were spinned down in the PCR plate, and the supernatant was discard, leaving 10 <italic>&#x000B5;</italic>l medium. The cells were then lysed using single cell lysis buffer (1 mM EDTA, 10% Tween-20) and then boiled at 65 &#x000B0;C for 2 h; 95 &#x000B0;C for 30 min. PCR was then performed with cell lysis buffer and allele-specific primers followed by electrophoresis on a 1% agrose gel. The DNA gel was scanned using a gel imaging system (Tannon 3500R; Tanon Science &amp; Technology Co., Ltd., Shanghai, China).</p></sec>
<sec>
<title>Luciferase assay</title>
<p>The NQO1-ARE promoter was cloned into pGL3-Basic (Promega, Madison, WI, USA) vector by standard methods. For the luciferase assay, the A549 cells were transiently transfected with the luciferase construct and &#x003B2;-galactosidase (as an internal control). The cells were transfected using PolyJet reagent (Invitrogen) according to the manufacturer's instructions. Luciferase activity was determined using a luminometer. The medium was removed from the cells, and the cells were then lysed in 100 <italic>&#x000B5;</italic>l of extraction buffer (100 mM KPO<sub>4</sub>, pH 7.4, 4.0 mM ATP, 1.5 mM MgSO<sub>4</sub>, 1.0 mM dithiothreitol and 0.1% Triton X-100). Cell lysates (25 <italic>&#x000B5;</italic>l) were added to 350 <italic>&#x000B5;</italic>l of luciferase assay buffer (100 mM KPO<sub>4</sub>, pH 7.4, 4.0 mM ATP, and 1.5 mM MgSO<sub>4</sub>) and then 100 <italic>&#x000B5;</italic>l of 1.0 mM D-Luciferin was injected into each culture tube using a luminometer that integrated the luminescence over 10 sec. &#x003B2;-galactosidase activity was measured using <italic>o</italic>-nitrophenyl-&#x003B2;-D-galactopyranoside (ONPG; Sigma-Aldrich) as a substrate. Briefly, the cell lysates were incubated with ONPG (0.4 mg/ml) in reaction buffer (0.1 M sodium phosphate pH 7.5, 10 mM KCl, 1 mM MgCl<sub>2</sub>) for 1 h and the absorbance was then measured at 405 nm. The data are expressed as a ratio of luciferase to &#x003B2;-galactosidase activity.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>All data are presented as the means &#x000B1; standard deviation (SD). Statistical analysis was carried out using one-way ANOVA followed by the Scheffe test using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Statistical significance was set at p&lt;0.05.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>OPC protects against cell death and attenuates oxidative stress in A549 cells exposed to H<sub>2</sub>O<sub>2</sub></title>
<p>We first examined the potential effects of OPC in A549 cells. The resutls of MTT assay for cell survival shown in <xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1A</xref> demonstrated that the viability of the A549 cells was not significantly decreased when the cells were treated with OPC at the concentration of &#x02264;50 mg/l. However, at the concentration of &#x02265;100 mg/l OPC, A549 cell viability was slightly, but significantly decreased (<xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1A</xref>). Subsequently, H<sub>2</sub>O<sub>2</sub>-induced oxidative damage was investigated in the A549 cells by MTT assay. The viability of the A549 cells decreased following exposure to H<sub>2</sub>O<sub>2</sub> in a dose-dependent manner. Following 12 h of exposure to 100 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub>, cell viability decreased to 70% of the control, whereas 200 <italic>&#x000B5;</italic>M decreased cell viability to 50% and this concentration was utilized for further experiments (<xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1B</xref>). Significantly, treatment with OPC at 1&#x02013;50 mg/l (non-cytotoxic concentrations) markedly attenuated the H<sub>2</sub>O<sub>2</sub>-induced decrease in A549 cell viability (<xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1C</xref>). We then examined the effects of OPC on the activities of a series of phase II metabolizing enzymes and antioxidants. The results demonstrated that the enzyme activities of SOD, CAT and GSH-Px were significantly decreased in the H<sub>2</sub>O<sub>2</sub>-treated A549 cells, and that OPC at 50 mg/l enhanced their activities (<xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1D&#x02013;F</xref>). We also determined the contents of ROS and MDA within the A549 cells. We found that the levels of ROS and MDA were significantly elevated in the H<sub>2</sub>O<sub>2</sub>-exposed cells. Similarly, OPC at 50 mg/l significantly decreased the contents of ROS and MDA (<xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1G and H</xref>). These results indicated that OPC exerted potent antioxidant effects on H<sub>2</sub>O<sub>2</sub>-exposed A549 cells.</p></sec>
<sec>
<title>OPC increases the transcriptional activity of Nrf2 and the Nrf2-dependent antioxidant response of A549 cells exposed to H<sub>2</sub>O<sub>2</sub></title>
<p>In order to elucidate the potential mechanisms responsible for the protective effects of OPC against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress, the A549 cells were exposed to H<sub>2</sub>O<sub>2</sub> for 12 h following treatment or not with OPC. We then examined the mRNA and protein expression of Nrf2 and Nrf2 target genes. We found that H<sub>2</sub>O<sub>2</sub> increased the mRNA expression of Nrf2 and Nrf2 target genes and this increase was further enhanced by OPC (<xref rid="f2-ijmm-39-06-1548" ref-type="fig">Fig. 2A</xref>). Furthermore, the results of western blot analyses revealed that the nuclear protein expression of Nrf2 was significantly increased by H<sub>2</sub>O<sub>2</sub> and OPC; however, the cytoplasmic protein expression of Nrf2 was not altered by H<sub>2</sub>O<sub>2</sub> and OPC (<xref rid="f2-ijmm-39-06-1548" ref-type="fig">Fig. 2B</xref>). As regards HO-1, NQO1 and TXNRD1, their protein expression was significantly increased by OPC (<xref rid="f2-ijmm-39-06-1548" ref-type="fig">Fig. 2C</xref>). Subsequently, to investigate the effects of OPC on Nrf2 transcriptional activity under conditions of H<sub>2</sub>O<sub>2</sub>- induced oxidative stress, the enzymatic activity of NQO1 was also examined. As observed with the mRNA expression of NQO1, which increased following treatment with OPC in the A549 cells, the enzymatic activity of NQO1 was also increased in the A549 cells following treatment with OPC (<xref rid="f2-ijmm-39-06-1548" ref-type="fig">Fig. 2D</xref>). Taken together, these results indicate that OPC promotes the nuclear translocation of Nrf2, leading to the enhanced expression of its target genes implicated in the protective effects of OPC against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in A549 cells.</p></sec>
<sec>
<title>Effects of the knockout of Nrf2 in A549 using the CRISPR/Cas9 system</title>
<p>As Nrf2 was above shown to participate in the protective effects of OPC against oxidative stress, we knocked out Nrf2 in the A549 cells in order to further explore the overall influence of the process. We used the CRISPR/Cas9 system that has been reported to efficiently disrupt genes in cells (<xref ref-type="bibr" rid="b21-ijmm-39-06-1548">21</xref>). As a result, we obtained 2 Nrf2 knockout A549 clones, 4# and 5#. The DNA sequences of the 2 clones revealed a deletion of the 1173 and 1162 bases in both alleles (<xref rid="f3-ijmm-39-06-1548" ref-type="fig">Fig. 3A and B</xref>). DNA gel-image indicated that Nrf2 deletion &gt;1,000 bases between exon 3 and exon 4 (<xref rid="f3-ijmm-39-06-1548" ref-type="fig">Fig. 3C</xref>). Western blot analysis revealed that Nrf2 was completely knocked out in the 2 clone cells by the absence of Nrf2 expression (<xref rid="f3-ijmm-39-06-1548" ref-type="fig">Fig. 3D</xref>).</p></sec>
<sec>
<title>Nrf2 mediates H<sub>2</sub>O<sub>2</sub>-induced antioxidant activity</title>
<p>We then characterized the function of OPC in A549 cells in which Nrf2 had been knocked out. Note that in the A549 cells in which Nrf2 was knocked out, H<sub>2</sub>O<sub>2</sub>-induced cell death was exacerbated (<xref rid="f4-ijmm-39-06-1548" ref-type="fig">Fig. 4A</xref>), indicating that OPC exerts its protective effects via basal Nrf2. The results shown in <xref rid="f2-ijmm-39-06-1548" ref-type="fig">Fig. 2A and C</xref> demonstrated that the mRNA and protein expression levels of HO-1, NQO1 and TXNRD1 were significantly increased following treatment with OPC. However, the antioxidant activity was almost abolished with Nrf2 knockout (<xref rid="f4-ijmm-39-06-1548" ref-type="fig">Fig. 4D&#x02013;F</xref>). OPC was almost ineffective against H<sub>2</sub>O<sub>2</sub>-mediated SOD, CAT and GSH-Px activity when Nrf2 was knocked out (<xref rid="f4-ijmm-39-06-1548" ref-type="fig">Fig. 4D&#x02013;F</xref>). This finding suggested that OPC protected the A549 cells against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress via the Nrf2-ARE pathway.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The increased production of ROS (<xref ref-type="bibr" rid="b22-ijmm-39-06-1548">22</xref>,<xref ref-type="bibr" rid="b23-ijmm-39-06-1548">23</xref>) is frequently observed in cancer cells compared to normal cells, and this may be selectively used to promote tumor cell death. Cellular exposure to xenobiotics, drugs, heavy metals and ionizing radiation is able to generate ROS that leads to oxidative stress and has a profound impact on the survival and evolution of all living organisms (<xref ref-type="bibr" rid="b24-ijmm-39-06-1548">24</xref>). OPC, as a natural compound, has high bioactivity and provides significantly greater protection against free radicals, and free radical-induced lipid peroxidation and DNA damage than vitamins C and E, and &#x003B2;-carotene both in <italic>in vitro</italic> and <italic>in vivo</italic> models (<xref ref-type="bibr" rid="b25-ijmm-39-06-1548">25</xref>). In this study, we induced oxidative stress in A549 cells using H<sub>2</sub>O<sub>2</sub> to uncover the underlying mechanisms of H<sub>2</sub>O<sub>2</sub>-induced oxidative toxicity. Cells have internal antioxidant defense enzymes, such as GSH-Px, CAT and SOD, which are critical protective measures against oxidative stress-related disorders. It has been previously suggested that antioxidants protect cells against oxidative damage by reducing lipid peroxidation products and elevating the levels of GSH-Px and SOD activities (<xref ref-type="bibr" rid="b26-ijmm-39-06-1548">26</xref>). In this study, the activities of these antioxidant defense enzymes were observed to be significantly reduced in A549 cells following exposure to H<sub>2</sub>O<sub>2</sub>, and pre-treatment of the cells with OPC for 5 h significantly attenuated the effects of H<sub>2</sub>O<sub>2</sub> on these enzymes, thereby boosting the protective effects of the enzymes for the cells (<xref rid="f1-ijmm-39-06-1548" ref-type="fig">Fig. 1D&#x02013;F</xref>).</p>
<p>Nrf2 is a transcription factor that is activated by increased ROS production, which induces the transcription of several antioxidant and detoxification enzymes, including HO-1, NQO1 and TXNRD1 (<xref ref-type="bibr" rid="b27-ijmm-39-06-1548">27</xref>). In this study, we present our findings that OPC is able to upregulate the Nrf2 signaling pathway under conditions of H<sub>2</sub>O<sub>2</sub>-induced oxidatve stress by enhancing the activation of ARE. Based on the molecular data obtained, we used CRISPR/gRNA technology to knockout Nrf2 and demonstrated that OPC is able to upregulate the Nrf2-dependent antioxidant response under conditions of H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. Previous studies have shown that an advantage of the constitutive activation of Nrf2 for cancer cells is the enhancement of proliferation. This enhanced proliferation enhances the ability of the cancer cells to detoxify the elevated levels of ROS associated with constant division and growth (<xref ref-type="bibr" rid="b28-ijmm-39-06-1548">28</xref>,<xref ref-type="bibr" rid="b29-ijmm-39-06-1548">29</xref>).</p>
<p>In conclusion, the results obtained in this study demonstrate that the protective effects of OPC against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress are dependent on the enhanced activity of Nrf2, which facilitates cells viability even in a highly oxidative environment.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-ijmm-39-06-1548"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatsuno</surname><given-names>T</given-names></name><name><surname>Jinno</surname><given-names>M</given-names></name><name><surname>Arima</surname><given-names>Y</given-names></name><name><surname>Kawabata</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Yahagi</surname><given-names>N</given-names></name><name><surname>Takano</surname><given-names>F</given-names></name><name><surname>Ohta</surname><given-names>T</given-names></name></person-group><article-title>Anti-inflammatory and anti-melanogenic proanthocyanidin oligomers from peanut skin</article-title><source>Biol Pharm Bull</source><volume>35</volume><fpage>909</fpage><lpage>916</lpage><year>2012</year><pub-id pub-id-type="doi">10.1248/bpb.35.909</pub-id><pub-id pub-id-type="pmid">22687483</pub-id></element-citation></ref>
<ref id="b2-ijmm-39-06-1548"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ED;a-Conesa</surname><given-names>MT</given-names></name><name><surname>Tribolo</surname><given-names>S</given-names></name><name><surname>Guyot</surname><given-names>S</given-names></name><name><surname>Tom&#x000E1;s-Barber&#x000E1;n</surname><given-names>FA</given-names></name><name><surname>Kroon</surname><given-names>PA</given-names></name></person-group><article-title>Oligomeric procyanidins inhibit cell migration and modulate the expression of migration and proliferation associated genes in human umbilical vascular endothelial cells</article-title><source>Mol Nutr Food Res</source><volume>53</volume><fpage>266</fpage><lpage>276</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/mnfr.200800134</pub-id></element-citation></ref>
<ref id="b3-ijmm-39-06-1548"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>SD</given-names></name><name><surname>Parikh</surname><given-names>H</given-names></name><name><surname>Bagchi</surname><given-names>D</given-names></name></person-group><article-title>Proanthocyanidin exposure to B6C3F1 mice significantly attenuates dimethylnitrosamine-induced liver tumor induction and mortality by differentially modulating programmed and unprogrammed cell deaths</article-title><source>Mutat Res</source><volume>579</volume><fpage>81</fpage><lpage>106</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2005.02.017</pub-id><pub-id pub-id-type="pmid">16197968</pub-id></element-citation></ref>
<ref id="b4-ijmm-39-06-1548"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Fei</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name></person-group><article-title>Protective effect of oligomeric proanthocyanidins against alcohol-induced liver steatosis and injury in mice</article-title><source>Biochem Biophys Res Commun</source><volume>458</volume><fpage>757</fpage><lpage>762</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2015.01.153</pub-id><pub-id pub-id-type="pmid">25680468</pub-id></element-citation></ref>
<ref id="b5-ijmm-39-06-1548"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberhardt</surname><given-names>MV</given-names></name><name><surname>Lee</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>RH</given-names></name></person-group><article-title>Antioxidant activity of fresh apples</article-title><source>Nature</source><volume>405</volume><fpage>903</fpage><lpage>904</lpage><year>2000</year><pub-id pub-id-type="pmid">10879522</pub-id></element-citation></ref>
<ref id="b6-ijmm-39-06-1548"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forkink</surname><given-names>M</given-names></name><name><surname>Basit</surname><given-names>F</given-names></name><name><surname>Teixeira</surname><given-names>J</given-names></name><name><surname>Swarts</surname><given-names>HG</given-names></name><name><surname>Koopman</surname><given-names>WJ</given-names></name><name><surname>Willems</surname><given-names>PH</given-names></name></person-group><article-title>Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells</article-title><source>Redox Biol</source><volume>6</volume><fpage>607</fpage><lpage>616</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.redox.2015.09.003</pub-id><pub-id pub-id-type="pmid">26516986</pub-id><pub-id pub-id-type="pmcid">4635408</pub-id></element-citation></ref>
<ref id="b7-ijmm-39-06-1548"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>Y</given-names></name><name><surname>Chouchani</surname><given-names>ET</given-names></name><name><surname>James</surname><given-names>AM</given-names></name><name><surname>Menger</surname><given-names>KE</given-names></name><name><surname>Cochem&#x000E9;</surname><given-names>HM</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name></person-group><article-title>Mitochondrial redox signalling at a glance</article-title><source>J Cell Sci</source><volume>125</volume><fpage>801</fpage><lpage>806</lpage><year>2012</year><pub-id pub-id-type="doi">10.1242/jcs.098475</pub-id><pub-id pub-id-type="pmid">22448036</pub-id></element-citation></ref>
<ref id="b8-ijmm-39-06-1548"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Autr&#x000E9;aux</surname><given-names>B</given-names></name><name><surname>Toledano</surname><given-names>MB</given-names></name></person-group><article-title>ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>813</fpage><lpage>824</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/nrm2256</pub-id><pub-id pub-id-type="pmid">17848967</pub-id></element-citation></ref>
<ref id="b9-ijmm-39-06-1548"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zubovych</surname><given-names>IO</given-names></name><name><surname>Straud</surname><given-names>S</given-names></name><name><surname>Roth</surname><given-names>MG</given-names></name></person-group><article-title>Mitochondrial dysfunction confers resistance to multiple drugs in Caenorhabditis elegans</article-title><source>Mol Biol Cell</source><volume>21</volume><fpage>956</fpage><lpage>969</lpage><year>2010</year><pub-id pub-id-type="doi">10.1091/mbc.E09-08-0673</pub-id><pub-id pub-id-type="pmid">20089839</pub-id><pub-id pub-id-type="pmcid">2836976</pub-id></element-citation></ref>
<ref id="b10-ijmm-39-06-1548"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelicano</surname><given-names>H</given-names></name><name><surname>Carney</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name></person-group><article-title>ROS stress in cancer cells and therapeutic implications</article-title><source>Drug Resist Updat</source><volume>7</volume><fpage>97</fpage><lpage>110</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.drup.2004.01.004</pub-id><pub-id pub-id-type="pmid">15158766</pub-id></element-citation></ref>
<ref id="b11-ijmm-39-06-1548"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shasby</surname><given-names>DM</given-names></name><name><surname>Vanbenthuysen</surname><given-names>KM</given-names></name><name><surname>Tate</surname><given-names>RM</given-names></name><name><surname>Shasby</surname><given-names>SS</given-names></name><name><surname>McMurtry</surname><given-names>I</given-names></name><name><surname>Repine</surname><given-names>JE</given-names></name></person-group><article-title>Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: Role of oxygen radicals</article-title><source>Am Rev Respir Dis</source><volume>125</volume><fpage>443</fpage><lpage>447</lpage><year>1982</year><pub-id pub-id-type="pmid">7073114</pub-id></element-citation></ref>
<ref id="b12-ijmm-39-06-1548"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>A</given-names></name><name><surname>Ohta</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes</article-title><source>Methods Enzymol</source><volume>378</volume><fpage>273</fpage><lpage>286</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/S0076-6879(04)78021-0</pub-id><pub-id pub-id-type="pmid">15038975</pub-id></element-citation></ref>
<ref id="b13-ijmm-39-06-1548"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>Wakabayashi</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Regulatory mechanisms of cellular response to oxidative stress</article-title><source>Free Radic Res</source><volume>31</volume><fpage>319</fpage><lpage>324</lpage><year>1999</year><pub-id pub-id-type="doi">10.1080/10715769900300881</pub-id><pub-id pub-id-type="pmid">10517536</pub-id></element-citation></ref>
<ref id="b14-ijmm-39-06-1548"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okawa</surname><given-names>H</given-names></name><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>A</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Kensler</surname><given-names>TW</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity</article-title><source>Biochem Biophys Res Commun</source><volume>339</volume><fpage>79</fpage><lpage>88</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.10.185</pub-id></element-citation></ref>
<ref id="b15-ijmm-39-06-1548"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niture</surname><given-names>SK</given-names></name><name><surname>Khatri</surname><given-names>R</given-names></name><name><surname>Jaiswal</surname><given-names>AK</given-names></name></person-group><article-title>Regulation of Nrf2-an update</article-title><source>Free Radic Biol Med</source><volume>66</volume><fpage>36</fpage><lpage>44</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.02.008</pub-id></element-citation></ref>
<ref id="b16-ijmm-39-06-1548"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villeneuve</surname><given-names>NF</given-names></name><name><surname>Tian</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Lau</surname><given-names>A</given-names></name><name><surname>Chapman</surname><given-names>E</given-names></name><name><surname>Fang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>DD</given-names></name></person-group><article-title>USP15 negatively regulates Nrf2 through deubiquitination of Keap1</article-title><source>Mol Cell</source><volume>51</volume><fpage>68</fpage><lpage>79</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.molcel.2013.04.022</pub-id><pub-id pub-id-type="pmid">23727018</pub-id><pub-id pub-id-type="pmcid">3732832</pub-id></element-citation></ref>
<ref id="b17-ijmm-39-06-1548"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaiahgari</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Kleeberger</surname><given-names>SR</given-names></name><name><surname>Cho</surname><given-names>HY</given-names></name><name><surname>Reddy</surname><given-names>SP</given-names></name></person-group><article-title>Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells</article-title><source>Antioxid Redox Signal</source><volume>8</volume><fpage>43</fpage><lpage>52</lpage><year>2006</year><pub-id pub-id-type="doi">10.1089/ars.2006.8.43</pub-id><pub-id pub-id-type="pmid">16487036</pub-id></element-citation></ref>
<ref id="b18-ijmm-39-06-1548"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>KJ</given-names></name><name><surname>Lee</surname><given-names>JT</given-names></name><name><surname>Joe</surname><given-names>EH</given-names></name><name><surname>Kwon</surname><given-names>TK</given-names></name></person-group><article-title>An I&#x003BA;B&#x003B1; phosphorylation inhibitor induces heme oxygenase-1(HO-1) expression through the activation of reactive oxygen species (ROS)-Nrf2-ARE signaling and ROS-PI3K/Akt signaling in an NF-&#x003BA;B-independent mechanism</article-title><source>Cell Signal</source><volume>23</volume><fpage>1505</fpage><lpage>1513</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.cellsig.2011.05.013</pub-id><pub-id pub-id-type="pmid">21620964</pub-id></element-citation></ref>
<ref id="b19-ijmm-39-06-1548"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeNicola</surname><given-names>GM</given-names></name><name><surname>Karreth</surname><given-names>FA</given-names></name><name><surname>Humpton</surname><given-names>TJ</given-names></name><name><surname>Gopinathan</surname><given-names>A</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><name><surname>Frese</surname><given-names>K</given-names></name><name><surname>Mangal</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>KH</given-names></name><name><surname>Yeo</surname><given-names>CJ</given-names></name><name><surname>Calhoun</surname><given-names>ES</given-names></name><etal/></person-group><article-title>Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</article-title><source>Nature</source><volume>475</volume><fpage>106</fpage><lpage>109</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/nature10189</pub-id><pub-id pub-id-type="pmid">21734707</pub-id><pub-id pub-id-type="pmcid">3404470</pub-id></element-citation></ref>
<ref id="b20-ijmm-39-06-1548"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Ran</surname><given-names>FA</given-names></name><name><surname>Cox</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Barretto</surname><given-names>R</given-names></name><name><surname>Habib</surname><given-names>N</given-names></name><name><surname>Hsu</surname><given-names>PD</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Marraffini</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Multiplex genome engineering using CRISPR/Cas systems</article-title><source>Science</source><volume>339</volume><fpage>819</fpage><lpage>823</lpage><year>2013</year><pub-id pub-id-type="doi">10.1126/science.1231143</pub-id><pub-id pub-id-type="pmid">23287718</pub-id><pub-id pub-id-type="pmcid">3795411</pub-id></element-citation></ref>
<ref id="b21-ijmm-39-06-1548"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>PD</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><article-title>Development and applications of CRISPR-Cas9 for genome engineering</article-title><source>Cell</source><volume>157</volume><fpage>1262</fpage><lpage>1278</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.cell.2014.05.010</pub-id><pub-id pub-id-type="pmid">24906146</pub-id><pub-id pub-id-type="pmcid">4343198</pub-id></element-citation></ref>
<ref id="b22-ijmm-39-06-1548"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogrunc</surname><given-names>M</given-names></name><name><surname>Di Micco</surname><given-names>R</given-names></name><name><surname>Liontos</surname><given-names>M</given-names></name><name><surname>Bombardelli</surname><given-names>L</given-names></name><name><surname>Mione</surname><given-names>M</given-names></name><name><surname>Fumagalli</surname><given-names>M</given-names></name><name><surname>Gorgoulis</surname><given-names>VG</given-names></name><name><surname>d'Adda di Fagagna</surname><given-names>F</given-names></name></person-group><article-title>Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation</article-title><source>Cell Death Differ</source><volume>21</volume><fpage>998</fpage><lpage>1012</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/cdd.2014.16</pub-id><pub-id pub-id-type="pmid">24583638</pub-id><pub-id pub-id-type="pmcid">4013514</pub-id></element-citation></ref>
<ref id="b23-ijmm-39-06-1548"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>AK</given-names></name></person-group><article-title>Nrf2 Signaling in coordinated activation of antioxidant gene expression</article-title><source>Free Rad Biol Med</source><volume>36</volume><fpage>1199</fpage><lpage>1207</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.02.074</pub-id><pub-id pub-id-type="pmid">15110384</pub-id></element-citation></ref>
<ref id="b24-ijmm-39-06-1548"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>JW</given-names></name><name><surname>Wetterhahn</surname><given-names>KE</given-names></name></person-group><article-title>Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage</article-title><source>Mol Carcinog</source><volume>2</volume><fpage>274</fpage><lpage>286</lpage><year>1989</year><pub-id pub-id-type="doi">10.1002/mc.2940020508</pub-id><pub-id pub-id-type="pmid">2604865</pub-id></element-citation></ref>
<ref id="b25-ijmm-39-06-1548"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagchi</surname><given-names>D</given-names></name><name><surname>Bagchi</surname><given-names>M</given-names></name><name><surname>Stohs</surname><given-names>SJ</given-names></name><name><surname>Das</surname><given-names>DK</given-names></name><name><surname>Ray</surname><given-names>SD</given-names></name><name><surname>Kuszynski</surname><given-names>CA</given-names></name><name><surname>Joshi</surname><given-names>SS</given-names></name><name><surname>Pruess</surname><given-names>HG</given-names></name></person-group><article-title>Free radicals and grape seed proanthocyanidin extract: Importance in human health and disease prevention</article-title><source>Toxicology</source><volume>148</volume><fpage>187</fpage><lpage>197</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0300-483X(00)00210-9</pub-id><pub-id pub-id-type="pmid">10962138</pub-id></element-citation></ref>
<ref id="b26-ijmm-39-06-1548"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>GQ</given-names></name></person-group><article-title>Scutellarin attenuates oxidative glutamate toxicity in PC12 cells</article-title><source>Planta Med</source><volume>70</volume><fpage>427</fpage><lpage>431</lpage><year>2004</year><pub-id pub-id-type="doi">10.1055/s-2004-818970</pub-id><pub-id pub-id-type="pmid">15124087</pub-id></element-citation></ref>
<ref id="b27-ijmm-39-06-1548"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>E</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Roles nrf2 plays in myeloid cells and related disorders</article-title><source>Oxid Med Cell Longev</source><volume>2013</volume><fpage>529219</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/529219</pub-id><pub-id pub-id-type="pmid">23819012</pub-id><pub-id pub-id-type="pmcid">3684031</pub-id></element-citation></ref>
<ref id="b28-ijmm-39-06-1548"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>NM</given-names></name><name><surname>Kleeberger</surname><given-names>SR</given-names></name><name><surname>Bream</surname><given-names>JH</given-names></name><name><surname>Fallon</surname><given-names>PG</given-names></name><name><surname>Kensler</surname><given-names>TW</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>SP</given-names></name></person-group><article-title>Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling</article-title><source>Oncogene</source><volume>27</volume><fpage>5821</fpage><lpage>5832</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/onc.2008.188</pub-id><pub-id pub-id-type="pmid">18542053</pub-id><pub-id pub-id-type="pmcid">2646365</pub-id></element-citation></ref>
<ref id="b29-ijmm-39-06-1548"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homma</surname><given-names>S</given-names></name><name><surname>Ishii</surname><given-names>Y</given-names></name><name><surname>Morishima</surname><given-names>Y</given-names></name><name><surname>Yamadori</surname><given-names>T</given-names></name><name><surname>Matsuno</surname><given-names>Y</given-names></name><name><surname>Haraguchi</surname><given-names>N</given-names></name><name><surname>Kikuchi</surname><given-names>N</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Hizawa</surname><given-names>N</given-names></name><etal/></person-group><article-title>Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer</article-title><source>Clin Cancer Res</source><volume>15</volume><fpage>3423</fpage><lpage>3432</lpage><year>2009</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-08-2822</pub-id><pub-id pub-id-type="pmid">19417020</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijmm-39-06-1548" position="float">
<label>Figure 1</label>
<caption>
<p>Oligomeric proanthocyanidins (OPCs) alleviate H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in A549 cells. A549 cells (A and C) were treated with the indicated concentrations of OPC for 5 h and/or H<sub>2</sub>O<sub>2</sub> for 12 h, and cell survival was examined by MTT assay. (B) Cells were exosed to various concentrations of H<sub>2</sub>O<sub>2</sub> and cell viability was examined. Experiments were repeated 3 times with similar results obtained (same for all figures). For each assay, n=6 (same for all figures). Bars indicate the means &#x000B1; SD (same for all figures). Effects of OPC on superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) levels in H<sub>2</sub>O<sub>2</sub>-exposed A549 cells. Cells were pre-treated with 50 mg/l OPC for 5 h and then exposed to 200 <italic>&#x000B5;</italic>M of H<sub>2</sub>O<sub>2</sub> for 12 h (D&#x02013;G). (H) Effect of OPC on H<sub>2</sub>O<sub>2</sub>-induced ROS production in A549 cells. DCFH-DA fluorescence reflects the level of ROS. The values are expressed as the means &#x000B1; SD (n=3). <sup>&#x0002A;</sup>p&lt;0.05 vs. control group; <sup>&#x0002A;&#x0002A;</sup>p&lt;0.01 vs. control group; <sup>#</sup>p&lt;0.05 vs. H<sub>2</sub>O<sub>2</sub> only group.</p></caption>
<graphic xlink:href="IJMM-39-06-1548-g00.tif"/></fig>
<fig id="f2-ijmm-39-06-1548" position="float">
<label>Figure 2</label>
<caption>
<p>Oligomeric proanthocyanidins (OPCs) increase the transcriptional activity of NF-E2-related factor 2 (Nrf2) and the Nrf2-dependent antioxidant response. A549 cells were pre-treated with 50 mg/l OPC for 5 h and then exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h. RNA was extracted and RT-qPCR was performed. Values were normalized to actin, and the controls were set equal to 1. <sup>&#x0002A;</sup>p&lt;0.05 vs. control group; <sup>#</sup>p&lt;0.05 vs. H<sub>2</sub>O<sub>2</sub> only group. A549 cells were exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h with or without 50 mg/l OPC. Western blot analyses for protein abundance of Nrf2 in the cytoplasm and nucleus. A549 cells were exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h with or without 50 mg/l OPC. Cell lysates were subjected to western blot analysis using Nrf2, NAD(P)H quinone dehydrogenase 1 (NQO1), heme oxygenase-1 (HO-1) and thioredoxin reductase 1 (TXNRD1) antibodies. A549 cells were transfected with expression plasmids for NQO-1-ARE promoter-firefly luciferase and &#x003B2;-galactosidase as an internal control for 36 h then exposed to H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>m) for 12 h, with or without pre-treatment with OPC (50 mg/l). Both firefly and &#x003B2;-galactosidase were measured, and results are presented as firefly/&#x003B2;-galactosidase activity. <sup>&#x0002A;</sup>p&lt;0.05 vs. control group; <sup>&#x0002A;&#x0002A;</sup>p&lt;0.01 vs. control group; <sup>#</sup>p&lt;0.05 vs. H<sub>2</sub>O<sub>2</sub> only group.</p></caption>
<graphic xlink:href="IJMM-39-06-1548-g01.tif"/></fig>
<fig id="f3-ijmm-39-06-1548" position="float">
<label>Figure 3</label>
<caption>
<p>Generation of NF-E2-related factor 2 (Nrf2) knockout A549 cells using the CRISPR/Cas9 system. (A) The sgRNA (blue) was designed to aim at 20 pairs of bases in exon 3 and exon 4 of Nrf2. (B) Sequences of the wild-type (WT) Nrf2 locus and DSBs induced by Cas9 of Nrf2 locus in 2 established A549 cell lines (Nrf2-KO 4#) 4# and (Nrf2-KO 5#) 5#. Lnes 1, 2, 3 and 6 shown an allele of approximately 1,500 bp. The 4# and 5# cell lines had one allele with &gt;1,100 bp deletion. The PAM sequence is indicated by red color. (C) Allele-specific PCR analysis of Nrf2 genome in A549 cells. (D) Western blot analysis of Nrf2 in A549, 4# and 5# cells.</p></caption>
<graphic xlink:href="IJMM-39-06-1548-g02.tif"/></fig>
<fig id="f4-ijmm-39-06-1548" position="float">
<label>Figure 4</label>
<caption>
<p>NF-E2-related factor 2 (Nrf2) mediates oligomeric proanthocyanidins (OPC)-induced antioxidant activity. (A) Effect of OPC on cell viability in 4# and 5# cells. Cells were pre-treated with 1&#x02013;50 mg/l OPC 5 h and then exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h. Results are expressed as % viability of the control. Data are expressed as the means &#x000B1; SD (for each group n=6). <sup>&#x0002A;</sup>p&lt;0.05 vs. control group. (B) 4# and 5# cells were exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h with or without treatment with 50 mg/l OPC for 5 h. RNA was extracted and RT-qPCR was performed. Values were normalized to actin, and controls were set equal to 1. <sup>&#x0002A;</sup>p&lt;0.05 vs. control group. (C) 4# and 5# cells were exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 12 h with or without 50 mg/l OPC. Cell lysates were collected at 5 h post-treatment and subjected to western blot analysis using NAD(P)H quinone dehydrogenase 1 (NQO1), heme oxygenase-1 (HO-1) and thioredoxin reductase 1 (TXNRD1) antibodies. (D&#x02013;F) Effects of OPC on superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) level in H<sub>2</sub>O<sub>2</sub>-exposed 4# and 5# cells. Cells were pre-treated with 50mg/l OPC for 5 h and then exposed to 200 <italic>&#x000B5;</italic>M of H<sub>2</sub>O<sub>2</sub> for 12 h. Data are expressed as the means &#x000B1; SD (n=6). <sup>&#x0002A;</sup>p&lt;0.05 vs. control group.</p></caption>
<graphic xlink:href="IJMM-39-06-1548-g03.tif"/></fig>
<table-wrap id="tI-ijmm-39-06-1548" position="float">
<label>Table I</label>
<caption>
<p>Sequence of the primers used in RT-qPCR.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">Forward primer (5&#x02032;&#x02192;3&#x02032;)</th>
<th valign="top" align="center">Reverse primer (5&#x02032;&#x02192;3&#x02032;)</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Nrf2</td>
<td valign="top" align="left">GAGACAGGTGAATTTCTCCCAAT</td>
<td valign="top" align="left">GGGAATGTGGGCAACCTGGG</td></tr>
<tr>
<td valign="top" align="left">HO-1</td>
<td valign="top" align="left">CAGGCAGAGAATGCTGATTC</td>
<td valign="top" align="left">GCTCTTCTGGGAAGTAGACAGG</td></tr>
<tr>
<td valign="top" align="left">NQO1</td>
<td valign="top" align="left">AAGAAAGGATGGGAGGTGGT</td>
<td valign="top" align="left">GCTTCTTTTGTTCAGCCACA</td></tr>
<tr>
<td valign="top" align="left">TXNRD1</td>
<td valign="top" align="left">GGAACTAGATGGGGTCTCGG</td>
<td valign="top" align="left">TCTTGCAGGGCTTGTCCTAA</td></tr>
<tr>
<td valign="top" align="left">&#x003B2;-actin</td>
<td valign="top" align="left">GATCATTGCTCCTCCTGAGC</td>
<td valign="top" align="left">ACTCCGCTTGCTGATCCAC</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-ijmm-39-06-1548">
<p>Nrf2, NF-E2-related factor 2; HO-1, heme oxygenase-1; NQO1, NAD(P)H quinone dehydrogenase 1; TXNRD1, thioredoxin reductase 1.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
